These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 38959275)
41. Lacrimal gland sparing IgG4-related disease in the orbit. Khan TT; Halat SK; Al Hariri AB Ocul Immunol Inflamm; 2013 Jun; 21(3):220-4. PubMed ID: 23480602 [TBL] [Abstract][Full Text] [Related]
42. Isolated Langerhans Cell Histiocytosis of the Lacrimal Gland in Conjunction With Mucosa-Associated Lymphoid Tissue Lymphoma and Elevated IgG4 Plasma Cells. Peck T; Bagg A; Zhang X; Armstrong B; Eagle RC; Milman T Ophthalmic Plast Reconstr Surg; 2019; 35(4):e92-e94. PubMed ID: 31219941 [TBL] [Abstract][Full Text] [Related]
43. Clinical, Radiological and Histopathological Features of Patients With Lacrimal Gland Enlargement. Jamshidian Tehrani M; Asadi Khameneh E; Pourseyed Iazarjani SZ; Ghadimi H; Nozarian Z; Mokhtari M Arch Iran Med; 2021 Dec; 24(12):910-915. PubMed ID: 35014239 [TBL] [Abstract][Full Text] [Related]
44. Spectrum of B-cell neoplasms associated with immunoglobulin G4-related disease. Ho RCW; Chan TSY; Au-Yeung R; Tang KHK; Hwang YY; Tse E; Kwong YL Ann Hematol; 2022 Jan; 101(1):99-108. PubMed ID: 34767055 [TBL] [Abstract][Full Text] [Related]
45. [Clinical and pathological analysis of 151 cases of tumors in lacrimal fossa]. Bi YW; Chen RJ Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):877-81. PubMed ID: 16271170 [TBL] [Abstract][Full Text] [Related]
46. Long-term outcomes of ocular adnexal lesions in IgG4-related ophthalmic disease. Kubota T; Katayama M; Nishimura R; Moritani S Br J Ophthalmol; 2020 Mar; 104(3):345-349. PubMed ID: 31272957 [TBL] [Abstract][Full Text] [Related]
47. Lacrimal gland orbital lobe cysts associated with MALT lymphoma and primary Sjögren's syndrome. Cassidy DT; McKelvie P; Harris GJ; Rose GE; McNab AA Orbit; 2005 Dec; 24(4):257-63. PubMed ID: 16354635 [TBL] [Abstract][Full Text] [Related]
48. IgG4-rich reactive lymphoid hyperplasia of the lacrimal gland. Mancera N; Bajric J; Margo CE Orbit; 2020 Aug; 39(4):285-288. PubMed ID: 31724473 [TBL] [Abstract][Full Text] [Related]
50. The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease. Takahira M; Goto H; Azumi A Jpn J Ophthalmol; 2024 Jul; 68(4):293-301. PubMed ID: 39037515 [TBL] [Abstract][Full Text] [Related]
51. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Cheuk W; Yuen HK; Chan AC; Shih LY; Kuo TT; Ma MW; Lo YF; Chan WK; Chan JK Am J Surg Pathol; 2008 Aug; 32(8):1159-67. PubMed ID: 18580683 [TBL] [Abstract][Full Text] [Related]
52. Lacrimal Gland and Orbital Lesions in Lat Hamaoka S; Takahira M; Kawano M; Yamada K; Ito K; Okuda T; Hatake S; Malissen M; Malissen B; Sugiyama K Curr Eye Res; 2022 Oct; 47(10):1405-1412. PubMed ID: 35913026 [TBL] [Abstract][Full Text] [Related]
53. Clinical research on benign lymphoepithelial lesions of lacrimal gland in 20 Chinese patients. Ma JM; Li J; Ge X; Li M; Li JR; Wang XN Chin Med J (Engl); 2015 Feb; 128(4):493-8. PubMed ID: 25673452 [TBL] [Abstract][Full Text] [Related]
54. Systemically disseminated extranodal marginal zone B-cell lymphoma of lacrimal gland in a patient with systemic lupus erythematosus. Lin YC; Kau HC; Kao SC; Hsu WM; Tsai CC Ophthalmic Plast Reconstr Surg; 2007; 23(1):72-3. PubMed ID: 17237702 [TBL] [Abstract][Full Text] [Related]
55. Intralesional Rituximab for the Treatment of Recurrent Ocular Adnexal Lymphoma. Demirci H; Kauh CY; Rajaii F; Elner VM Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S70-S71. PubMed ID: 26950471 [TBL] [Abstract][Full Text] [Related]
56. Malignancies in Immunoglobulin G4-related ophthalmic disease. Lai KKH; Li EYM; Chan RYC; Wong KCW; Yu JKS; Cheuk W; Hui YH; Cheng ACO; Chin JKY; Ip SK; Chan WH; Kwok JSW; Lam WC; Io IYF; Mak TST; Li KKW; Lam NM; Yip WWK; Young AL; Chan E; Ko CKL; Ko STC; Yuen HKL; Tham CCY; Pang CP; Chong KKL Eur J Ophthalmol; 2023 Jan; 33(1):171-181. PubMed ID: 35675196 [TBL] [Abstract][Full Text] [Related]
57. Evaluation of Orbital Lymphoproliferative and Inflammatory Disorders by Gene Expression Analysis. Al-Ghazzawi K; Baum SH; Pförtner R; Philipp S; Bechrakis N; Görtz G; Eckstein A; Mairinger FD; Oeverhaus M Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955742 [TBL] [Abstract][Full Text] [Related]
58. [The imaging signs and significances of the enlargement of the infraorbital nerve and the frontal nerve in orbital lymphoproliferative diseases]. Wang Y; Zhuo W; Hei Y; Tong QZ; Li TY Zhonghua Yan Ke Za Zhi; 2020 Nov; 56(11):832-838. PubMed ID: 33152841 [No Abstract] [Full Text] [Related]
59. Clinicopathologic features of orbital immunoglobulin G4-related disease (IgG4-RD): a case series and literature review. Mulay K; Aggarwal E; Honavar SG Graefes Arch Clin Exp Ophthalmol; 2015 May; 253(5):803-9. PubMed ID: 25572352 [TBL] [Abstract][Full Text] [Related]
60. Usefulness of Flow Cytometry in Diagnosis of IgG4-Related Ophthalmic Disease and Extranodal Marginal Zone B-Cell Lymphoma of the Ocular Adnexa. Kase S; Ishijima K; Uraki T; Suimon Y; Suzuki Y; Kase M; Ishida S Anticancer Res; 2017 Sep; 37(9):5001-5004. PubMed ID: 28870925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]